AARD vs BABA · $284.4M cap vs P/E 20, rev $137.30B
Aardvark Therapeutics, Inc. Common Stock (AARD) versus Alibaba Group Holding Ltd (BABA) — a side-by-side from cached financials, not a winner call.
Aardvark Therapeutics, Inc. Common Stock (AARD) is a biotechnology company listed on US.
Alibaba Group Holding Ltd (BABA) is a internet retail company listed on US.
AARD does not have a complete income-statement cache yet.
Latest reported BABA revenue for 2025-03-31 was $137.30B. Net income was $17.93B. Revenue was up 5.3% from 2024-03-31 to 2025-03-31. BABA currently screens at market cap $305.19B and trailing P/E 19.6.
AARD currently screens at market cap $284.4M. BABA currently screens at market cap $305.19B and trailing P/E 19.6.
Not investment advice. Open the AARD and BABA stock pages for the full models.
Not investment advice.